Skip to main content

Table 1 Patient demographics and baseline characteristics (Transition baseline)

From: Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate

Parameter

Underweight <19 kg/m2(n = 29)

Normal-weight 19- < 25 kg/m2(n = 229)

Overweight 25- < 30 kg/m2(n = 232)

Obese ≥30 kg/m2(n = 154)

Overall (N = 644)

Age (yrs), Mean (SD)

33.2 (11.20)

36.2 (10.57)

38.2 (10.85)

38.4 (9.81)

37.3 (10.58)

Men, n (%)

19 (65)

146 (64)

143 (62)

71 (46)

379 (59)

Race, n (%)

  White

19 (66)

147 (64)

139 (60)

82 (53)

387 (60)

  Black

3 (10)

30 (13)

37 (16)

50 (32)

120 (19)

  Asian

6 (21)

46 (20)

47 (20)

18 (12)

117 (18)

  Other

1 (3)

6 (3)

9 (4)

4 (3)

20 (3)

Baseline BMI (kg/m 2 ), Mean (SD)

18.0 (0.87)

22.5 (1.52)

27.1 (1.34)

35.4 (4.68)

27.0 (5.88)

Age at diagnosis of schizophrenia (years), Mean (SD)

25.4 (8.57)

25.4 (7.39)

26.0 (8.99)

25.4 (8.95)

25.6 (8.41)

Baseline total PANSS, Mean (SD)

77.1 (17.20)

71.4 (17.09)

72.6 (18.82)

72.8 (16.91)

72.4 (17.70)

Prior hospitalization, n (%)

  None

3 (10)

26 (11)

18 (8)

16 (10)

63 (10)

  Once

6 (21)

55 (24)

47 (20)

29 (19)

137 (21)

  Twice

9 (31)

49 (21)

48 (21)

40 (26)

146 (23)

  Three times

4 (14)

32 (14)

46 (20)

23 (15)

105 (16)

  Four times or more

7 (24)

67 (29)

73 (31)

46 (30)

193 (30)

  1. BMI-body metabolic index; PANSS-Positive and Negative Symptom Scale score; SD-standard deviation.